Employees: 00 (2023.0)Legal category: 5485Size: PMECreation date: 2016-10-03 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13013), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELURL PHARMACIE DU TECHNOPOLE : revenue, balance sheet and financial ratios
SELURL PHARMACIE DU TECHNOPOLE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13013),
this company of category PME
shows in 2023 a net income positive of 248 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE DU TECHNOPOLE (SIREN 823256318)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
247 847 €
131 263 €
109 172 €
102 036 €
108 112 €
100 072 €
-6 153 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SELURL PHARMACIE DU TECHNOPOLE generates positive net income of 248 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
247 847 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 40%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
40.096%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
69.41%
Solvency indicators evolution SELURL PHARMACIE DU TECHNOPOLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
-31777.372
747.392
445.995
314.314
221.317
155.882
40.096
Financial autonomy
-0.263
10.19
15.919
21.491
26.519
34.295
69.41
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
40.12023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-39 pts over 3 years
In 2023, the debt ratio of SELURL PHARMACIE DU TECHN... (40.10) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
69.41%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent+49 pts over 3 years
In 2023, the financial autonomy of SELURL PHARMACIE DU TECHN... (69.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 3596.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
3596.005
Liquidity indicators evolution SELURL PHARMACIE DU TECHNOPOLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
136.272
149.735
151.921
176.568
144.74
156.732
3596.005
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
3596.012023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Excellent+47 pts over 3 years
In 2023, the liquidity ratio of SELURL PHARMACIE DU TECHN... (3596.01) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELURL PHARMACIE DU TECHNOPOLE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELURL PHARMACIE DU TECHNOPOLE is estimated at
2 924 464 €
(range 1 778 506€ - 4 111 141€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1778k€2924k€4111k€
2 924 464 €Range: 1 778 506€ - 4 111 141€
NAF 5 année 2023
Valuation method used
Net Income Multiple
247 847 €
×
11.8x
=2 924 465 €
Range: 1 778 507€ - 4 111 141€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE DU TECHNOPOLE with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE DU TECHNOPOLE
What is the revenue of SELURL PHARMACIE DU TECHNOPOLE ?
The revenue of SELURL PHARMACIE DU TECHNOPOLE is not publicly disclosed (confidential accounts filed with INPI).
Is SELURL PHARMACIE DU TECHNOPOLE profitable?
Yes, SELURL PHARMACIE DU TECHNOPOLE generated a net profit of 248 k€ in 2023.
Where is the headquarters of SELURL PHARMACIE DU TECHNOPOLE ?
The headquarters of SELURL PHARMACIE DU TECHNOPOLE is located in MARSEILLE (13013), in the department Bouches-du-Rhone.
Where to find the tax return of SELURL PHARMACIE DU TECHNOPOLE ?
The tax return of SELURL PHARMACIE DU TECHNOPOLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE DU TECHNOPOLE operate?
SELURL PHARMACIE DU TECHNOPOLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart